|
Press Releases |
|
|
|
Tuesday, August 10, 2021 |
|
冠科美博(APOLLOMICS)APL-102 中國I期臨床研究完成首例患者給藥 |
冠科美博( Apollomics Inc.),一家致力於發現和開發腫瘤靶向和免疫新藥及其組合療法的創新生物製藥公司,今天宣佈,APL-102已經成功完成首例患者給藥。 more info >> |
|
冠科美博(APOLLOMICS)APL-102 中国I期临床研究完成首例患者给药 |
冠科美博( Apollomics Inc.),一家致力于发现和开发肿瘤靶向和免疫新药及其组合疗法的创新生物制药公司,今天宣布,APL-102已经成功完成首例患者给药。 more info >> |
|
Apollomics, Inc. Doses First Patient in a Phase I Clinical Trial of APL-102 |
Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination oncology therapies, today announced the successful dosing of the first patient in a Phase I clinical study of APL-102 in patients with advanced solid tumors. more info >> |
|
Thursday, May 20, 2021 |
|
冠科美博上海分公司正式开业 |
Apollomics, Inc. (冠科美博),一家致力于发现和开发肿瘤靶向和免疫新药及其组合疗法的创新生物制药公司,今天宣布, 冠科美博上海分公司正式开业并启用,地址位于上海市浦东张江高科技园区。 more info >> |
|
冠科美博上海分公司正式開業 |
Apollomics, Inc. (冠科美博),一家致力於發現和開發腫瘤靶向和免疫新藥及其組合療法的創新生物製藥公司,今天宣佈, 冠科美博上海分公司正式開業並啟用,地址位於上海市浦東張江高科技園區。 more info >> |
|
APOLLOMICS INC. ANNOUNCES OFFICIAL OPENING OF SHANGHAI BRANCH |
Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced that Apollomics Shanghai Branch has been officially opened and started its operations at Zhangjiang Hi-Tech Park, Pudong District, Shanghai. more info >> |
|
Tuesday, March 9, 2021 |
|
APOLLOMICS(冠科美博)任命K. PEONY YU余健鸿医学博士为首席医学官(CMO) |
Apollomics, Inc.(冠科美博),一家致力于发现和开发肿瘤靶向和免疫新药及其组合疗法的创新生物制药公司,今天宣布,任命K. PEONY YU(余健鸿)医学博士为首席医学官,余博士将于2021年3月16日正式上任。 more info >> |
|
APOLLOMICS(冠科美博)任命K. PEONY YU余健鴻醫學博士為首席醫學官(CMO) |
Apollomics, Inc.(冠科美博),一家致力於發現和開發腫瘤靶向和免疫新藥及其組合療法的創新生物製藥公司,今天宣佈,任命K. PEONY YU(余健鴻)醫學博士為首席醫學官,余博士將于2021年3月16日正式上任。 more info >> |
|
Apollomics, Inc. Appoints Seasoned Healthcare Executive K. Peony Yu, M.D., as Chief Medical Officer |
Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced the appointment of K. Peony Yu, M.D. as Chief Medical Officer. Dr. Yu will assume the role on March 16, 2021. more info >> |
|
Thursday, March 4, 2021 |
|
APOLLOMICS(冠科美博)UPROLESELAN注射液(APL-106)中国I期临床试验第一例受试者成功入组 |
Apollomics, Inc.(冠科美博),一家致力于发现和开发肿瘤靶向和免疫新药及其组合疗法的创新生物制药公司,今天宣布,Uproleselan注射液(APL-106)用于治疗成人复发或难治性急性髓系白血病的中国I期临床试验第一例受试者成功入组。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
How Artificial Intelligence Can Help Give Your Business a Boost
Jul 16, 2024 19:30 HKT/SGT
|
|
|
U.S. Polo Assn. Proudly Partners with the 2024 Outsourcing Inc. Royal Charity Polo Cup
Jul 16, 2024 19:00 HKT/SGT
|
|
|
Neste and Mitsubishi Corporation agree on strategic partnership to develop supply chains for renewable chemicals and plastics
Jul 16, 2024 18:36 JST
|
|
|
NEC technology reliably measures sea levels from a greater distance
Jul 16, 2024 17:45 JST
|
|
|
全球发展数字经济直播访谈会正式举办 外方来华参会高级别代表走进东方甄选直播间
Jul 16, 2024 15:08 HKT/SGT
|
|
|
巨星傳奇(6683.HK)解禁後首個交易日 收盤報10.4港元 升幅達2.97%
Jul 16, 2024 15:04 HKT/SGT
|
|
|
巨星传奇(6683.HK)解禁后首个交易日: 收盘报10.4港元 升幅达2.97%
Jul 16, 2024 14:58 HKT/SGT
|
|
|
全球發展數字經濟直播訪談會正式舉辦 外方來華參會高級別代表走進東方甄選直播間
Jul 16, 2024 14:25 HKT/SGT
|
|
|
Fujitsu and Cohere launch strategic partnership and joint development to provide generative AI for enterprises
Jul 16, 2024 15:13 JST
|
|
|
Komisi Penerbangan Malaysia Memilih TransNusa Sebagai Salah Satu Dari Dua Maskapai Asing Untuk Meluncurkan Penerbangan Dari Bandara Subang
Jul 16, 2024 14:00 HKT/SGT
|
|
|
エーザイ、ホスラブコナゾールのアジア・オセアニアにおけるライセンス契約を佐藤製薬と締結
Jul 16, 2024 13:00: JST
|
|
|
富士通とCohere、企業向け生成AIの提供に向けた戦略的パートナーシップを締結し、共同開発を開始
Jul 16, 2024 13:00: JST
|
|
|
卓悅集團旗下卓悅奧特萊斯Beauty Outlet開幕
Jul 15, 2024 22:58 HKT/SGT
|
|
|
Malaysian Aviation Commission Handpicks Indonesia's TransNusa Airlines as One of the Two Foreign Airlines to Operate from its distinguished Subang Airport
Jul 15, 2024 21:00 HKT/SGT
|
|
|
卓悦集团旗下卓悦奥特莱斯Beauty Outlet开幕
Jul 15, 2024 20:56 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|